TLSA Tiziana Life Sciences Ltd

Nasdaq tizianalifesciences.com


$ 1.92 $ 0.03 (1.57 %)    

Friday, 24-Oct-2025 10:15:35 EDT
QQQ $ 616.50 $ 0.50 (0.08 %)
DIA $ 470.69 $ 0.82 (0.17 %)
SPY $ 676.50 $ 0.03 (0 %)
TLT $ 91.42 $ -0.15 (-0.16 %)
GLD $ 379.57 $ 1.00 (0.26 %)
$ 1.9
$ 1.90
$ 1.91 x 37
$ 1.97 x 300
$ 1.90 - $ 1.94
$ 0.63 - $ 2.60
163,543
na
nm
$ -0.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tiziana-announces-it-will-advance-its-second-asset-a-fully-human-anti-il-6-receptor-monoclonal-antibody-tzls-501-tiziana-will-pursue-non-dilutive-funding-strategies-for-the-development-of-tzls-501-while-continuing-to-advance-intranasal-foralumab-as-its-lead-program

Tiziana Life Sciences, Ltd. (NASDAQ: TLSA) ("Tiziana" or the "Company"), today announces it will advance its se...

 tiziana-life-sciences-chairman-gabriele-cerrone-buys-25k-shares-at-160-now-holds-3628-of-issued-capital

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 lucid-is-now-shipping-adapters-that-let-customers-access-elon-musk-led-teslas-supercharger-network

Lucid ships adapters for Air Sedan allowing owners to access over 23,500 Tesla Supercharging stations across the U.S.

 tiziana-life-sciences-announced-immunologic-findings-from-the-treatment-of-a-moderate-alzheimers-disease-patient-with-intranasal-foralumab

Transcriptional analysis of white blood cells before and after foralumab therapy revealed profound immune modulatory effects. S...

 tiziana-life-sciences-executive-chairman-and-founder-gabriele-cerrone-increases-stake-to-3702-with-15000-share-purchase-total-holding-reaches-4325m

Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing break...

 tiziana-life-sciences-announces-results-of-pet-scan-showing-marked-reduction-in-microglia-activation-associated-with-neuroinflammation-in-ad-patient-treated-with-intranasal-foralumab

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 tiziana-life-sciences-announces-comprehensive-positive-results-from-study-of-nasal-foralumab-in-patients-with-multiple-sclerosis

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION